| Sep 3 |
Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring
|
| Aug 17 |
Movano (NASDAQ:MOVE) Will Have To Spend Its Cash Wisely
|
| Aug 14 |
Movano Inc. (MOVE) Q2 2024 Earnings Call Transcript
|
| Aug 14 |
Movano GAAP EPS of -$0.06 beats by $0.04
|
| Aug 14 |
Movano Health Reports Q2 2024 Financial Results and Provides Business Update
|
| Aug 5 |
Movano Health Provides Progress Update on EvieMED Regulatory Filing
|
| Aug 5 |
Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024
|
| Jun 28 |
Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event
|
| Jun 13 |
Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion
|
| Jun 10 |
MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease
|
